Abstract
Re-analysis of the VISTA trial of bortezomib in frontline therapy for transplant-ineligible myeloma patients has demonstrated that achieving a complete response is statistically correlated with a better outcome.
Cite
CITATION STYLE
APA
Spencer, A. (2010, November 11). No longer the poor relations. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2010-07-297556
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free